Latest News and Press Releases

Visiongain has published a new report entitled Allergic Rhinitis Drugs Market Report 2023-2033. It includes profiles of Allergic Rhinitis Drugs Market and Forecasts, Market Segment by Size by...

Visiongain has published a new report entitled Allergic Rhinitis Drugs Market Report 2023-2033. It includes profiles of Allergic Rhinitis Drugs Market and Forecasts, Market Segment by Size by...

Pune, India, May 05, 2022 (GLOBE NEWSWIRE) -- Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer’s drugs which in turn is driving the global Alzheimer’s drugs market,...

Visiongain has published a new report on Alzheimer’s Drugs Market Report to 2031: Forecasts by Drugs (Donepezil, Rivastigmine, Galantamine, and Memantine), By Distribution Channel (Hospital...

Pune, India, July 14, 2021 (GLOBE NEWSWIRE) -- Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer’s drugs which in turn is driving the global Alzheimer’s drugs market,...

Pune, India, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer’s drugs which in turn is driving the global market, says Fortune...

New York, NY, Sept. 06, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine, and Combined Drug) and by...

SEATTLE, May 23, 2018 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global dementia drugs market was valued US$ 13.90 Billion in 2017 and is projected to exhibit a CAGR of 8.4% over...

Albany, NY, Jan. 19, 2018 (GLOBE NEWSWIRE) -- According to Transparency Market Research, the global market opportunity for Alzheimer's drugs is expected to scale to US$6.4 bn by 2025 after being...

Sarasota, FL, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine, and Combined Drug), by...